A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

Researchers from NTU Hospital and Academia Sinica have developed PanMETAI, a breakthrough AI metabolomics platform for early ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...

“Large-scale efforts need to be made" in the fight against these cancers, said paper author Dr. Ju Dong Yang.

Now, a Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic ...

Namodenoson (CF102) demonstrated a favorable safety profile in patients with advanced pancreatic ductal adenocarcinoma (PDAC) in a phase 2a clinical study, meeting the trial’s p ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of ...

Can-Fite stock jumps 20% after mid-stage data show namodenoson is well tolerated in advanced pancreatic cancer patients, ...

Cancer is the No. 1 cause of line-of-duty deaths among firefighters, who are 9% more likely than the general population to be ...

Oregon Health & Science University researchers have found that certain nerves that play an integral role in the body's "fight or flight" stress response can support pancreatic tumor growth. These ...